Clavulanic acid, a novel beta-lactamase inhibitor--a case study in drug discovery and development
Brown, A.G.
Drug Design and Delivery 1(1): 1-21
1986
ISSN/ISBN: 0884-2884 PMID: 3334541 Document Number: 278892
The research programme leading to the discovery of clavulanic acid and the olivanic acids (carbapenems) is reviewed. The beta-lactamase inhibitory properties of clavulanic acid and its development as a formulation with amoxycillin (Augmentina) and ticarcillin (Timentin) are described. The chemistry of clavulanic acid as well as the properties of the carbapenem family of antibiotics is outlined as are the other beta-lactamase inhibitors prompted by the development of clavulanic acid.
Document emailed within 1 workday
Related Documents
Shiono, A.; Kurihara, J.; Hayashi, M.; Suzuki, T.; Imai, K.; Yamanaka, H.; Takezawa, Y.; Kiren, H.; Okabe, K.; Tomaru, Y. 1993: Clinical evaluation of Augpenin (clavulanic acid-ticarcillin) in urinary tract infections: especially against beta-lactamase producing strains Hinyokika Kiyo. Acta Urologica Japonica 39(8): 777-782Jarlier, V. 1998: Beta-lactamase producers and other bacteria: which ones to take into consideration and when? the concept of beta-lactamase inhibitor Presse Medicale 27(Suppl 4): 17-18
Susan, M.; Hariharan, T.S.; Sonya, J. 2013: A comparative in vitro study of cephalosporin/beta-lactamase inhibitor combinations against gram negative bacilli Indian Journal of Physiology and Pharmacology 57(4): 425-431
Fuchs, P.C.; Barry, A.L. 1990: Implications of beta-lactamase-inhibitor combinations Journal of Reproductive Medicine 35(3 Suppl): 317-321
Aver'ianova, E.V.; Bogacheva, T.I.; Rozhanskaia, T.I.; Selezneva, A.A. 1984: Rapid method of determining beta-lactamase inhibitor activity Antibiotiki 29(4): 245-248
Stewardson-Krieger, P.; Naidu, S. 1981: Simultaneous recovery of beta-lactamase-negative and beta-lactamase-positive Haemophilus influenzae type b from cerebrospinal fluid of a neonate Pediatrics 68(2): 253-254
Bayraktar, B.; Toksoy, B.; Bulut, E. 2010: Detection of bla(CTX-M) beta-lactamase genes in extended-spectrum beta-lactamase producing gram-negative bacteria Mikrobiyoloji Bulteni 44(2): 187-196
Cuffini, A.M.; Tullio, V.; Ianni Palarchio, A.; Bonino, A.; Paizis, G.; Carlone, N.A. 1998: Enhanced effects of amoxycillin/clavulanic acid compared with amoxycillin and clavulanic acid alone on the susceptibility to immunodefenses of a penicillin-resistant strain of Streptococcus pneumoniae Drugs under Experimental and Clinical Research 24(4): 173-184
Baykal, A.; Cöplü, N.; Simşek, H.üs.; Esen, B.; Gür, D. 2012: The presence of extended spectrum beta-lactamase, KPC-type carbapenemase and plasmid-mediated AmpC beta-lactamase in E.coli and K.pneumoniae strains isolated from blood cultures Mikrobiyoloji Bulteni 46(2): 159-169
Jacobs, M.R.; Aronoff, S.C.; Johenning, S.; Shlaes, D.M.; Yamabe, S. 1986: Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli Antimicrobial Agents and Chemotherapy 29(6): 980-985
Grace, M.E.; Fu, K.P.; Gregory, F.J.; Hung, P.P. 1987: Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases Drugs under Experimental and Clinical Research 13(3): 145-148
Kasahara, K.; Moriyasu, Y.; Kushida, M. 1974: Drug resistance and beta-lactamase of the intestinal bacteria Rinsho Byori. Japanese Journal of Clinical Pathology 22(10 Suppl): 350
Hunter, J.E.; Corkill, J.E.; McLennan, A.G.; Fletcher, J.N.; Hart, C.A. 1993: Plasmid encoded beta-lactamases resistant to inhibition by clavulanic acid produced by calf faecal coliforms Research in Veterinary Science 55(3): 367-370
Koren, J.án.; Vaculíková, A. 2006: Development of Beta-lactamase resistance in enterobacteria Klinicka Mikrobiologie a Infekcni Lekarstvi 12(3): 103-107
Comanducci, A.; Piccolomini, R.; Oliva, B. 1976: Study of the action of combinations of beta-lactam antibiotics on the beta-lactamase produced by strains of Enterobacteriaceae Bollettino della Societa Italiana di Biologia Sperimentale 52(18): 1433-1439
Uri, F.I.; Sartawi, S.A.; Dajani, Y.F.; Masoud, A.A.; Barakat, H.F. 1992: Amoxycillin/clavulanic acid (augmentin) compared with triple drug therapy for pelvic inflammatory disease International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 38(1): 41-43
Mikołajczyk, J.; Kotulowa, W.; Kazimierczak, J.; Sikora, A.; Rogowska, W.; Cieślak, J. 1980: Beta-lactamase inhibitors. I. Synthesis and biological properties of penicillanic acid derivatives Acta Poloniae Pharmaceutica 37(6): 637-641
Frye, S.V.; Bramson, H.N.; Hermann, D.J.; Lee, F.W.; Sinhababu, A.K.; Tian, G. 1998: Discovery and development of GG745, a potent inhibitor of both isozymes of 5 alpha-reductase Pharmaceutical Biotechnology 11: 393-422
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282
Zhou, S.; Yuan, Y.; Guo, Z.; Zhao, Y. 2013: Polyclonal antibody production and immunoassay development for detection of beta-lactamase in milk Wei Sheng Yan Jiu 42(3): 386-391